Article written by Bruce Sylvester Researchers report that ivabradine, a drug used for heart failure, appears to improve symptoms of postural orthostatic tachycardia syndrome, also known as POTS.
Article written by Bruce Sylvester Colchicine, a gout treatment, appears to reduce the need for oxygen therapy in COVID-19 patients, researchers reported on Feb. 4, 2021 in the… read more.
Article written by Bruce Sylvester Women under 55 with type-2 diabetes have a 10-fold increased risk of developing coronary heart disease (CHD) during the two decades following diagnosis,… read more.
Article written by Bruce Sylvester Patients with pulmonary hypertension due to interstitial lung disease who were treated with inhaled treprostinil have achieved significantly improved exercise capacity compared with… read more.
Article written by Bruce Sylvester Antidepressants do not appear to provide significant back or osteoarthritis pain relief, even though they are widely prescribed for such purposes, researchers reported… read more.
Article written by Bruce Sylvester Researchers from a large European study report that those who drink regularly a modest amount of alcohol have an increased risk of developing… read more.
Article written by Bruce Sylvester Among persons with prediabetes, a lifestyle intervention can almost halve the risk of developing Type 2 diabetes, researchers from a large, new study… read more.
Article written by Bruce Sylvester Investigators from the QUAZAR trial report that treatment with oral azacytidine (CC-486), significantly improves survival in older patients, over age of 55, with… read more.
Article written by Bruce Sylvester The diabetes drug canagliflozin, which has already shown efficacy in slowing kidney disease, is also effective among patients with advanced kidney disease.
Article written by Bruce Sylvester. Rilonacept, an FDA approved drug for other inflammatory diseases, shows high efficacy for treating acute pericarditis, an inflammation of tissue around the heart.
The migraine treatment rimegepant also appears to have efficacy in preventing migraines, researchers reported on Dec. 15, 2020 in The Lancet.
Both high and low levels of lipoprotein cholesterol (LDL-C) appear to be associated with an elevated risk of all-cause death, researchers from a Danish general population study reported… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
